Kidney Cancer and Immunotherapy with Dr. Saby George
Vložit
- čas přidán 18. 06. 2024
- Dr. Saby George of Roswell Park Comprehensive Cancer Center leads a Q&A about combination therapies, clinical trials, and new promise in kidney cancer. #CRIsummit #Immunotherapy www.cancerresearch.org/virtua...
Immunotherapy for kidney cancer-also called renal cell cancer-has tremendously changed the treatment landscape and overall survival of patients with metastatic kidney cancer. Oncologists have seen positive results in combining immunotherapy with conventional treatments such as surgery, laparoscopy, ablation, and targeted therapy. www.cancerresearch.org/immuno...
00:00 - Welcome from Tamron Hall
01:02 - Why is Kidney Cancer Difficult to treat?
08:59 - Promise of Immunotherapy
09:15 - Live Q&A
In this video, Dr. George opens with an overview of kidney cancer and immunotherapy. He describes the characteristics of kidney cancer and why it is challenging to treat. He reviews the history of immunotherapy for kidney cancer, focusing particularly on a rapid period of discovery between 2015-2018 during which checkpoint inhibitors and combinations were first approved for kidney cancer. He looks to the future of immunotherapy for kidney cancer, discussing immunotherapy combination trials that show great promise.
Dr. George then fielded questions from the audience:
- What do you think are promising immunotherapies for kidney cancer?
- Do I need to discontinue my other treatments in order to receive immunotherapy?
- How long does it take for immunotherapy treatment to work and how will I know when it’s working?
- What is the difference between a “hot” tumor and a “cold” tumor?
- How long should we proceed with immunotherapy once a complete response has been achieved?
- What are potential side effects of immunotherapy? What are the immediate side effects and what are the long-term side effects? How are these side effect managed?
- How is COVID-19 affecting kidney cancer patient cancer treatments? And are kidney cancer patients more susceptible to COVID-19?
- Can I still receive a COVID-19 vaccine if I am on immunotherapy?
Dr. Saby George is a medical oncologist specializing in the management of kidney, prostate, and bladder cancers. An attending physician and associate professor of oncology within the Department of Medicine at Roswell Park Comprehensive Cancer Center, he is a passionate advocate of advancing patient care and quality of life through clinical research. Dr. George helped pave the way for approval of nivolumab, the ipilimumab/nivolumab combination, and similar checkpoint-inhibitor immunotherapies for treatment of some forms of kidney cancer through his role as Roswell Park site lead on several major international clinical trials. He continues to lead studies exploring emerging cancer therapies and treatment strategies. A Fellow of the American College of Physicians, Dr. George is board-certified in medical oncology. He holds an additional faculty appointment in the Department of Medicine within the University of Buffalo’s Jacobs School of Medicine and Biomedical Sciences.
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. www.cancerresearch.org
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.
The only reason I'm still alive today (and feeling pretty good) is because of Dr. George. Thanks man.
Thanks for sharing your story with us, Scott! Dr. George is great! :)
I wrote Scott Smith a message and it was deleted. Was it deleted by the Cancer Research Institute? If so why? We should be allowed to ask questions or interact with others. Other wise don't allow comments. Thank you
@@laura20367ify what when?
To bad immunotherapy only works on a small percentage of patients.
I think it would have been important to go into more statistical detail on the side effects. Especially considering how broad, debilitating and irreversible some of the effects can be. Not to mention the extent of the remedial treatments. I would have liked to hear what percent of patients experienced side effects that needed remedial treatment. And just as important, what are Disease Free Survival rates in terms of months or years? Also, any of these side effects can occur during or even after the use of these drugs have been discontinued! This should be expressed at nauseum. Are we playing poker with the hopes that the drug(s) treat the cancer progression as opposed to getting heart, lung or liver failure? I am a cancer patient and am disappointed that the dark side of these drugs are not expressed significantly. I'm not trying to disparage the use of these drug, however, for many years, drugs were approved to fight cancer that did more harm than good.
Really good information. Thank you
Thanks for tuning in!